AllianceBernstein’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$967K Hold
103,100
﹤0.01% 2306
2025
Q1
$733K Sell
103,100
-162,218
-61% -$1.15M ﹤0.01% 2388
2024
Q4
$3.09M Sell
265,318
-1,928,469
-88% -$22.5M ﹤0.01% 1734
2024
Q3
$45.1M Buy
2,193,787
+410,903
+23% +$8.44M 0.02% 632
2024
Q2
$39.9M Buy
1,782,884
+211,360
+13% +$4.73M 0.01% 664
2024
Q1
$43.2M Sell
1,571,524
-92,218
-6% -$2.54M 0.02% 649
2023
Q4
$50.7M Buy
1,663,742
+116,630
+8% +$3.56M 0.02% 577
2023
Q3
$48.9M Sell
1,547,112
-175,665
-10% -$5.55M 0.02% 560
2023
Q2
$70.3M Sell
1,722,777
-42,151
-2% -$1.72M 0.03% 482
2023
Q1
$65.8M Buy
1,764,928
+75,206
+4% +$2.8M 0.03% 488
2022
Q4
$59M Buy
1,689,722
+267,521
+19% +$9.33M 0.03% 525
2022
Q3
$79.6M Sell
1,422,201
-282,450
-17% -$15.8M 0.04% 418
2022
Q2
$88.2M Sell
1,704,651
-43,030
-2% -$2.23M 0.04% 411
2022
Q1
$127M Buy
1,747,681
+285,021
+19% +$20.7M 0.05% 336
2021
Q4
$173M Buy
1,462,660
+225,756
+18% +$26.7M 0.06% 290
2021
Q3
$166M Buy
1,236,904
+27,436
+2% +$3.68M 0.07% 275
2021
Q2
$196M Sell
1,209,468
-548,344
-31% -$88.8M 0.08% 238
2021
Q1
$141M Buy
1,757,812
+1,695,712
+2,731% +$136M 0.06% 299
2020
Q4
$3.38M Buy
62,100
+500
+0.8% +$27.2K ﹤0.01% 1699
2020
Q3
$1.23M Sell
61,600
-1,300
-2% -$25.9K ﹤0.01% 2089
2020
Q2
$1.32M Buy
62,900
+9,300
+17% +$195K ﹤0.01% 2051
2020
Q1
$656K Hold
53,600
﹤0.01% 2217
2019
Q4
$786K Hold
53,600
﹤0.01% 2364
2019
Q3
$716K Hold
53,600
﹤0.01% 2381
2019
Q2
$877K Hold
53,600
﹤0.01% 2365
2019
Q1
$915K Sell
53,600
-5,200
-9% -$88.8K ﹤0.01% 2275
2018
Q4
$803K Hold
58,800
﹤0.01% 2287
2018
Q3
$1.68M Hold
58,800
﹤0.01% 2055
2018
Q2
$1.61M Buy
58,800
+35,400
+151% +$969K ﹤0.01% 2063
2018
Q1
$494K Sell
23,400
-4,900
-17% -$103K ﹤0.01% 2513
2017
Q4
$544K Buy
28,300
+1,200
+4% +$23.1K ﹤0.01% 2495
2017
Q3
$673K Sell
27,100
-3,300
-11% -$82K ﹤0.01% 2455
2017
Q2
$486K Buy
30,400
+4,600
+18% +$73.5K ﹤0.01% 2610
2017
Q1
$364K Hold
25,800
﹤0.01% 2612
2016
Q4
$338K Buy
25,800
+2,900
+13% +$38K ﹤0.01% 2669
2016
Q3
$390K Buy
22,900
+2,600
+13% +$44.3K ﹤0.01% 2606
2016
Q2
$433K Buy
+20,300
New +$433K ﹤0.01% 2558